The effect of at least 1‐year use of omalizumab without interruption on relapse in patients with chronic spontaneous urticaria.

Autor: Su, Ozlem1 (AUTHOR), Bahali, Anil Gulsel1 (AUTHOR) anilirli@yahoo.com, Onsun, Nahide1 (AUTHOR)
Zdroj: Dermatologic Therapy. Nov/Dec2020, Vol. 33 Issue 6, p1-5. 5p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje